RIPK4 downregulation impairs Wnt3A-stimulated invasiveness via Wnt/β-catenin signaling in melanoma cells and tumor growth in vivo
出版年份 2023 全文链接
标题
RIPK4 downregulation impairs Wnt3A-stimulated invasiveness via Wnt/β-catenin signaling in melanoma cells and tumor growth in vivo
作者
关键词
-
出版物
CELLULAR SIGNALLING
Volume -, Issue -, Pages 110938
出版商
Elsevier BV
发表日期
2023-10-22
DOI
10.1016/j.cellsig.2023.110938
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Vemurafenib and Dabrafenib Downregulates RIPK4 Level
- (2023) Ewelina Madej et al. Cancers
- PLEKHA4 Promotes Wnt/beta-catenin Signaling-Mediated G1/S Transition and Proliferation in Melanoma
- (2021) Adnan Shami Shah et al. CANCER RESEARCH
- Resistance to Molecularly Targeted Therapies in Melanoma
- (2021) Meet Patel et al. Cancers
- Deciphering the Functional Role of RIPK4 in Melanoma
- (2021) Ewelina Madej et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Silencing of RIPK4 inhibits epithelial‑mesenchymal transition by inactivating the Wnt/β‑catenin signaling pathway in osteosarcoma
- (2020) Zhigang Yi et al. Molecular Medicine Reports
- Temporal activation of WNT/β-catenin signaling is sufficient to inhibit SOX10 expression and block melanoma growth
- (2020) Rexhep Uka et al. ONCOGENE
- WNT Signaling in Melanoma
- (2020) Anna Gajos-Michniewicz et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- RIPK protein kinase family: Atypical lives of typical kinases
- (2020) Gregory D. Cuny et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Akt in cancer: Mediator and more
- (2019) Sundaramoorthy Revathidevi et al. SEMINARS IN CANCER BIOLOGY
- Plasticity of Drug-Naïve and Vemurafenib- or Trametinib-Resistant Melanoma Cells in Execution of Differentiation/Pigmentation Program
- (2019) Malgorzata Czyz et al. Journal of Oncology
- Current state of melanoma diagnosis and treatment
- (2019) Lauren E. Davis et al. CANCER BIOLOGY & THERAPY
- Comparative phosphorylation map of Dishevelled 3 links phospho-signatures to biological outputs
- (2019) Kateřina Hanáková et al. Cell Communication and Signaling
- RIPK4 promotes bladder urothelial carcinoma cell aggressiveness by upregulating VEGF-A through the NF-κB pathway
- (2018) Jian-Ye Liu et al. BRITISH JOURNAL OF CANCER
- RIPK4/PEBP1 axis promotes pancreatic cancer cell migration and invasion by activating RAF1/MEK/ERK signaling
- (2018) Zi-Hao Qi et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotype
- (2018) Tobias Sinnberg et al. Molecular Cancer
- A20 regulates canonical wnt-signaling through an interaction with RIPK4
- (2018) Brooke N. Nakamura et al. PLoS One
- Control of neural crest multipotency by Wnt signaling and the Lin28/let-7 axis
- (2018) Debadrita Bhattacharya et al. eLife
- Vemurafenib and trametinib reduce expression of CTGF and IL-8 in V600EBRAF melanoma cells
- (2017) Mariusz L Hartman et al. LABORATORY INVESTIGATION
- Influence of protein kinase RIPK4 expression on the apoptosis and proliferation of chondrocytes in osteoarthritis
- (2017) Lixue Zou et al. Molecular Medicine Reports
- In the Wnt-er of life: Wnt signalling in melanoma and ageing
- (2016) Amanpreet Kaur et al. BRITISH JOURNAL OF CANCER
- Wnt signaling in cancer
- (2016) T Zhan et al. ONCOGENE
- The role of Wnt/β-catenin signaling pathway in melanoma epithelial-to-mesenchymal-like switching: evidences from patients-derived cell lines
- (2016) Daniela Kovacs et al. Oncotarget
- Activated Wnt/ss-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model
- (2009) A. J. Chien et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now